Page last updated: 2024-09-03

mozavaptan and Lung Neoplasms

mozavaptan has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iguchi, H; Kawahara, M; Kodama, T; Kuriyama, T; Mori, K; Sakurai, M; Shijubo, N; Shinkai, T; Sugiura, T; Yamaguchi, K	1

Trials

1 trial(s) available for mozavaptan and Lung Neoplasms

Article	Year
Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome. Japanese journal of clinical oncology, 2011, Volume: 41, Issue:1 Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Antineoplastic Agents; Benzamides; Benzazepines; Biomarkers; Carcinoma, Small Cell; Female; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Palliative Care; Quality of Life; Sodium; Thymus Neoplasms; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms	2011

Article

Year

Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome.

Japanese journal of clinical oncology, 2011, Volume: 41, Issue:1

Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Antineoplastic Agents; Benzamides; Benzazepines; Biomarkers; Carcinoma, Small Cell; Female; Humans; Inappropriate ADH Syndrome; Lung Neoplasms; Male; Middle Aged; Palliative Care; Quality of Life; Sodium; Thymus Neoplasms; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms

2011